A snapshot of Canada’s healthcare startup landscape will be on display at the upcoming MedCity INVEST, an innovative boutique healthcare investing conference taking place May 21-22 at the Ritz Carlton Hotel in Chicago. Four innovative companies present their approaches to solving vulnerabilities in healthcare. The session is sponsored by the Consulate General of Canada.
The group of four healthcare startups spans women’s health, orthopedics, remote Parkinson’s patient monitoring, and AI and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners, will moderate the session.
FemTherapeutics is a medical technology company that develops “Invisalign for gynecology”. Leveraging artificial intelligence and 3D printing, the gynecology platform offers patient-specific intravaginal devices for common pelvic conditions. The first product is a customized pessary to treat pelvic organ prolapse and stress urinary incontinence, which affect 50% of women during their lifetime. FemTherapeutics is building the infrastructure to enable expansion into other pelvic health categories, including menstruation and sexual wellness, labor and delivery, oncology and more.
Reach Orthopedics has developed a shoulder implant to treat patients suffering from massive irreparable rotator cuff tears (MIRCT). The Reach Implant is designed to restore shoulder function, relieve chronic pain, and protect the acromion from associated stress fractures. Currently, there is no standard of care for middle-aged individuals (40–70 years) suffering from MIRCT. The durability of the Reach implant makes it ideal for use in this population and provides a bridge solution.
PragmaClin Research aims to transform the world of neurological care with a remote patient monitoring system called PRIMS. The platform uses depth cameras along with patient-reported data to revolutionize the accuracy and efficiency of diagnosing and monitoring Parkinson’s disease. PRIMS integrates seamlessly into clinical workflows and provides neurologists and healthcare providers with a comprehensive solution for assessing motor and non-motor symptoms. Its patient-centered approach not only increases diagnostic precision, but also supports patients with valuable insights into their disease, thereby promoting a proactive attitude in disease management. By bridging the gap between traditional assessments and cutting-edge technology, PRIMS sets a new standard in neurological care, ensuring patients receive timely, tailored and transformative treatment strategies.
OPTT Health is a technology company that uses AI and patient reports as the primary source of analysis to generate actionable clinical insights. These insights support psychiatric care teams in providing personalized, data-driven and evidence-based care, enabling continuous monitoring and informed decision-making throughout the patient’s care journey.